Astrana Health Stock Buy Hold or Sell Recommendation
| ASTH Stock | 33.47 0.23 0.68% |
Given the investment horizon of 90 days and your above-average risk tolerance, our recommendation regarding Astrana Health is 'Hold'. The recommendation algorithm takes into account all of Astrana Health's available fundamental, technical, and predictive indicators you will find on this site.
Check out Astrana Health Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. For more detail on how to invest in Astrana Stock please use our How to Invest in Astrana Health guide. In addition, we conduct extensive research on individual companies such as Astrana and provide practical buy, sell, or hold advice based on investors' investing horizon and their risk tolerance towards Astrana Health. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.
Astrana |
Execute Astrana Health Buy or Sell Advice
The Astrana recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Astrana Health. Macroaxis does not own or have any residual interests in Astrana Health or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Astrana Health's advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Hold
Market Performance | Very Weak | Details | |
Volatility | Very steady | Details | |
Hype Condition | Under hyped | Details | |
Current Valuation | Undervalued | Details | |
Odds Of Distress | Very Small | Details | |
Economic Sensitivity | Almost mirrors the market | Details | |
Investor Sentiment | Impartial | Details | |
Analyst Consensus | Strong Buy | Details | |
Financial Strenth (F Score) | Healthy | Details | |
Financial Leverage | Not Rated | Details | |
Reporting Quality (M-Score) | Possible Manipulator | Details |
Astrana Health Trading Alerts and Improvement Suggestions
| Astrana Health generated a negative expected return over the last 90 days | |
| Astrana Health has high historical volatility and very poor performance | |
| Astrana Health is unlikely to experience financial distress in the next 2 years | |
| Astrana Health was previously known as Astrana Health and was traded on NASDAQ Exchange under the symbol AMEH. | |
| About 24.0% of the company shares are held by company insiders | |
| Latest headline from finance.yahoo.com: Astrana Health sheds 12 percent this week, as yearly returns fall more in line with earnings growth |
Astrana Health Returns Distribution Density
The distribution of Astrana Health's historical returns is an attempt to chart the uncertainty of Astrana Health's future price movements. The chart of the probability distribution of Astrana Health daily returns describes the distribution of returns around its average expected value. We use Astrana Health price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Astrana Health returns is essential to provide solid investment advice for Astrana Health.
| Mean Return | -0.74 | Value At Risk | -3.96 | Potential Upside | 3.13 | Standard Deviation | 3.44 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Astrana Health historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
Astrana Stock Institutional Investors
| Shares | Northern Trust Corp | 2024-09-30 | 424.1 K | Morgan Stanley - Brokerage Accounts | 2024-09-30 | 342.6 K | Fort Washington Investment Advisors Inc | 2024-09-30 | 299.8 K | Bank Of New York Mellon Corp | 2024-09-30 | 268.7 K | Goldman Sachs Group Inc | 2024-09-30 | 258.9 K | Royal Bank Of Canada | 2024-09-30 | 254.6 K | Bellevue Group Ag | 2024-09-30 | 254.2 K | Amvescap Plc. | 2024-09-30 | 241.8 K | Atria Wealth Solutions, Inc. | 2024-09-30 | 237.4 K | Blackrock Inc | 2024-06-30 | 6.4 M | Vanguard Group Inc | 2024-09-30 | 4.7 M |
Astrana Health Cash Flow Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Change In Cash | (3.6M) | 90.0M | 39.1M | 54.9M | 6.1M | 5.8M | |
| Free Cash Flow | 12.6M | 45.0M | 51.1M | 59.2M | 39.7M | 41.7M | |
| Other Non Cash Items | 5.3M | (102.1M) | 22.9M | 15.2M | 6.4M | 9.7M | |
| Capital Expenditures | 1.0M | 1.2M | 19.2M | 22.9M | 28.5M | 30.0M | |
| Net Income | 17.7M | 122.3M | 49.3M | 50.5M | 57.8M | 60.7M | |
| End Period Cash Flow | 104.0M | 194.0M | 233.1M | 288.0M | 294.2M | 308.9M | |
| Change To Inventory | (29.6M) | (5.8M) | 1.0M | 31.4M | 12.2M | 12.8M | |
| Depreciation | 18.8M | 18.4M | 17.5M | 17.5M | 17.7M | 8.9M | |
| Investments | (129.7M) | 108.0M | 32.4M | 34.3M | (65.5M) | (62.2M) | |
| Change Receivables | (5.8M) | 15.6M | (26.8M) | (28.8M) | (25.9M) | (24.6M) | |
| Net Borrowings | 281.4M | (105K) | (58.0M) | (828K) | (952.2K) | (904.6K) | |
| Dividends Paid | 61.7M | 51.3M | 31.1M | 14.0M | (62.1M) | (59.0M) | |
| Change To Netincome | 2.3M | (106.7M) | (2.0M) | (3.7M) | (3.3M) | (3.5M) |
Astrana Health Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Astrana Health or Health Care Providers & Services sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Astrana Health's price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Astrana stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over Dow Jones | -0.78 | |
β | Beta against Dow Jones | 1.09 | |
σ | Overall volatility | 3.52 | |
Ir | Information ratio | -0.22 |
Astrana Health Volatility Alert
Astrana Health exhibits very low volatility with skewness of -2.89 and kurtosis of 16.39. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure Astrana Health's stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact Astrana Health's stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.Astrana Health Fundamentals Vs Peers
Comparing Astrana Health's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Astrana Health's direct or indirect competition across all of the common fundamentals between Astrana Health and the related equities. This way, we can detect undervalued stocks with similar characteristics as Astrana Health or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Astrana Health's fundamental indicators could also be used in its relative valuation, which is a method of valuing Astrana Health by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare Astrana Health to competition |
| Fundamentals | Astrana Health | Peer Average |
| Return On Equity | 0.1 | -0.31 |
| Return On Asset | 0.0449 | -0.14 |
| Profit Margin | 0.04 % | (1.27) % |
| Operating Margin | 0.06 % | (5.51) % |
| Current Valuation | 1.65 B | 16.62 B |
| Shares Outstanding | 45.65 M | 571.82 M |
| Shares Owned By Insiders | 23.60 % | 10.09 % |
| Shares Owned By Institutions | 45.99 % | 39.21 % |
| Number Of Shares Shorted | 1.64 M | 4.71 M |
| Price To Book | 2.17 X | 9.51 X |
| Price To Sales | 0.89 X | 11.42 X |
| Revenue | 1.39 B | 9.43 B |
| Gross Profit | 199.48 M | 27.38 B |
| EBITDA | 123.69 M | 3.9 B |
| Net Income | 57.85 M | 570.98 M |
| Total Debt | 321.01 M | 5.32 B |
| Book Value Per Share | 14.75 X | 1.93 K |
| Cash Flow From Operations | 68.23 M | 971.22 M |
| Short Ratio | 4.86 X | 4.00 X |
| Earnings Per Share | 1.30 X | 3.12 X |
| Target Price | 64.5 | |
| Number Of Employees | 1.8 K | 18.84 K |
| Beta | 1.24 | -0.15 |
| Market Capitalization | 1.53 B | 19.03 B |
| Total Asset | 933.36 M | 29.47 B |
| Retained Earnings | 243.13 M | 9.33 B |
| Working Capital | 242.83 M | 1.48 B |
| Net Asset | 933.36 M |
Note: Disposition of 5100 shares by Kitayama Mitchell W of Astrana Health at 43.09 subject to Rule 16b-3 [view details]
Astrana Health Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Astrana . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
| Accumulation Distribution | 13781.44 | |||
| Daily Balance Of Power | (0.19) | |||
| Rate Of Daily Change | 0.99 | |||
| Day Median Price | 33.8 | |||
| Day Typical Price | 33.69 | |||
| Price Action Indicator | (0.45) | |||
| Period Momentum Indicator | (0.23) |
About Astrana Health Buy or Sell Advice
When is the right time to buy or sell Astrana Health? Buying financial instruments such as Astrana Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having Astrana Health in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Printing and Publishing Thematic Idea Now
Printing and Publishing
Fama and French investing themes focus on testing asset pricing under different economic assumptions. The Printing and Publishing theme has 21 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Printing and Publishing Theme or any other thematic opportunities.
| View All Next | Launch |
Check out Astrana Health Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. For more detail on how to invest in Astrana Stock please use our How to Invest in Astrana Health guide.You can also try the ETFs module to find actively traded Exchange Traded Funds (ETF) from around the world.
Is Health Care Providers & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Astrana Health. If investors know Astrana will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Astrana Health listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.30) | Earnings Share 1.3 | Revenue Per Share 36.415 | Quarterly Revenue Growth 0.375 | Return On Assets 0.0449 |
The market value of Astrana Health is measured differently than its book value, which is the value of Astrana that is recorded on the company's balance sheet. Investors also form their own opinion of Astrana Health's value that differs from its market value or its book value, called intrinsic value, which is Astrana Health's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Astrana Health's market value can be influenced by many factors that don't directly affect Astrana Health's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Astrana Health's value and its price as these two are different measures arrived at by different means. Investors typically determine if Astrana Health is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Astrana Health's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.